Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit in Adults 40 to 65: Study

A new study has found that Pfizer’s COVID-19 oral antiviral pill Paxlovid appears to provide little or no benefit for younger adults.

Please wait...

Author:

Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments